- Obama ‘cavalier’ in hiding foreign aid order, judge rules
- Prince Charles: Muslims are driving Christians from Mideast through persecution
- Gitmo’s first commander: Close the prison down
- Google’s newest photography find: Just wink and shoot
- Detroit’s Heidelberg art project hit by 8 fires in 8 months
- Pa. police pull people over for random DNA tests for feds
- NASA pushing hard to get back into space game
- Harvard student to face federal charges for bomb hoax
- Ronnie Biggs of ‘Great Train Robbery’ fame dies, 84
- Pope Francis wins another ‘Person of the Year’ — from gay rights magazine
Preemie birth preventive spikes from $10 to $1,500
ATLANTA (AP) - The price of preventing preterm labor is about to go through the roof.
A drug for high-risk pregnant women has cost about $10 to $20 per injection. Next week, the price shoots up to $1,500 a dose, meaning the total cost during a pregnancy could be as much as $30,000.
That’s because the drug, a form of progesterone given as a weekly shot, has been made cheaply for years, mixed in special pharmacies that custom-compound treatments that are not federally approved.
But recently, KV Pharmaceutical of suburban St.Louis won government approval to exclusively sell the drug, known as Makena (Mah-KEE’-Nah). The March of Dimes and many obstetricians supported that because it means quality will be more consistent and it will be easier to get.
None of them anticipated the dramatic price hike, though _ especially since most of the cost for development and research was shouldered by others in the past.
“That’s a huge increase for something that can’t be costing them that much to make. For crying out loud, this is about making money,” said Dr. Roger Snow, deputy medical director for Massachusetts’ Medicaid program.
Doctors say the price hike may deter low-income women from getting the drug, leading to more premature births. And it will certainly be a huge financial burden for health insurance companies and government programs that have been paying for it.
The cost is justified to avoid the mental and physical disabilities that can come with very premature births, said KV Pharmaceutical chief executive Gregory J. Divis Jr. The cost of care for a preemie is estimated at $51,000 in the first year alone.
The U.S. Food and Drug Administration is not involved in setting the price for the drugs it approves.
But Snow and others said someone is going to have to pay the higher price. Some of the burden will fall on health insurance companies, which will have to raise premiums or other costs to their other customers. And some will fall on cash-strapped state Medicaid programs, which may be forced to stop paying for the drug or enroll fewer people.
By John R. Bolton
The president fiddles at his domestic altar while the world burns
- U.S. Army mulls wiping out memory of Robert E. Lee, 'Stonewall' Jackson
- IRS pays tax cheats hundreds of millions of dollars
- HURT: D.C. gets the vapors, calls sequester too much
- Top Democrats reject court ruling over NSA spying on Americans
- BOLTON: Nero in the White House
- EDITORIAL: Al Gore, soothsayer
- Obama mocks Putin, picks gay athletes for Sochi delegation
- We told you so: Conservatives foresaw polygamy ruling
- Army to cut up to 4,000 captains and majors
- Senators in rush to pass budget vow to undo cut to military retirement pay
Independent voices from the The Washington Times Communities
A libertarian look at breaking news and political trends by author Tom Mullen.
Find the latest news and happening that effect those in the Washington D.C., Northern Virginia and Maryland Metro region.
Southern Fried Politics from the Lens of a Persian-American Millennial
Wall Street news for retail investors who want to know what's going on.
Top 10 handguns in the U.S.
Extraordinary day at Redskins Park
White House pets gone wild!
Let it snow